Patents for C12P 21 - Preparation of peptides or proteins (112,499)
09/2003
09/04/2003US20030166082 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166081 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166080 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166078 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166077 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166076 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166075 For stimulating release of tumor necrosis factor, and/or cellular proliferation/differentiation of chondrocytes/pericytes/adipocytes/endothelial cells by contacting blood with polypeptide; cancer diagnosis
09/04/2003US20030166074 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166073 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
09/04/2003US20030166071 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166063 High level insect expression of rage proteins
09/04/2003US20030166062 Solubilizing and recovering genetically engineered troponin produced as inclusion bodies
09/04/2003US20030166061 14273 receptor, a novel G-protein coupled receptor
09/04/2003US20030166057 Method and apparatus for the production of soluble MHC antigens and uses thereof
09/04/2003US20030166053 Plasmid which prolongs bacterial viability during fermentation
09/04/2003US20030166051 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/04/2003US20030166044 Novel proteins
09/04/2003US20030166041 Nucleotide sequences coding tim mitochondrial protein (TRP) which comprises zinc finger membrane protein for treating, diagnosing and preventing cancer and neurodegenerative diseases
09/04/2003US20030166024 Nucleotide sequences coding monoclonal antibody for the prevention, treatment and diagnosis of viral, inflammatory and tumor diseases; gene therapy
09/04/2003US20030166019 Immunoglobulin for use in diagnosis of nervous system and psychological disorders
09/04/2003US20030166011 Comprises immunoglobulin for treating arteriosclerosis, cancer and skin disorders; immunoassays
09/04/2003US20030166009 DNA molecules encoding the melanocortin 4 receptor protein from rhesus monkey
09/04/2003US20030166004 Comprises synthetic or genetically engineered peptide or polypeptide which comprises endothelial cell binding peptides (ECBP) for inhibit angiogenesis and related diseases such as cancer, arthritis and vision defects
09/04/2003US20030165981 Comprises cell proliferation and/or differentiation factors which contain signal sequences and functioning in hematopoietic systems and immune systems for diagnosis and treatment of autoimmune, infectious and cancer disorders
09/04/2003US20030165958 Test and model for Alzheimer's disease
09/04/2003US20030165950 Inducing the production of antibodies, in vivo, that specifically bind to nicotine. These conjugates comprise a nicotine hapten conjugated to an immunogenic carrier protein. The novel conjugates preserve the chirality of nicotine in
09/04/2003US20030165934 Methods and compositions in checkpoint signaling
09/04/2003US20030165924 Comprises nucleotide sequences transcribed in cells which accumulate multiple intracellular lipid droplets for diagnosing atherosclerosis
09/04/2003US20030165909 Screening cell sample for presence of lung nucleotide sequences (LS170) for diagnosing, classifying, monitoring, prognosing, in situ imaging, preventing or treating lung diseases, tumors or metastases
09/04/2003US20030165907 Human glycine transporter type 2
09/04/2003US20030165875 Novel receptor TREM (triggering receptor expressed on myeloid cells) and uses thereof
09/04/2003US20030165874 Nucleotide sequences probes for diagnosing and treating seizure disorders; restriction fragment length polymorphisms
09/04/2003US20030165820 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
09/04/2003US20030165540 Sentinel virus II
09/04/2003US20030165528 Streptococcus pyogenes antigens
09/04/2003US20030165519 Administering complex of protein taken from original tumor
09/04/2003US20030165514 Modulate immunology response
09/04/2003US20030165507 Postexposure prophylaxis therapy
09/04/2003US20030165501 Protein antagonist; insulin resistance; muscle disorders
09/04/2003US20030165497 RRP sequences and knockout mice and uses thereof
09/04/2003US20030165496 Alzheimer's disease
09/04/2003US20030165494 Rheumatic diseases; anticholesterol agents; cardiovascular disorders; multiple sclerosis
09/04/2003US20030165480 Using swine organs; controlling gene expression
09/04/2003US20030165459 Binding to tumor necrosis factor
09/04/2003CA2517027A1 Minicell compositions and methods
09/04/2003CA2477530A1 Novel glucose 6-oxidases
09/04/2003CA2477440A1 Reaction solution for cell-free protein synthesis, method of preparing the same and protein synthesis method using the same
09/04/2003CA2477409A1 Process for the preparation of hypoallergenic major birch pollen allergen rbet v 1
09/04/2003CA2477295A1 Trans-splicing mediated imaging of gene expression
09/04/2003CA2477249A1 Novel type-1 cytokine receptor glm-r
09/04/2003CA2477170A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003CA2476776A1 Reagents and treatment methods for autoimmune diseases
09/04/2003CA2476666A1 Haemophilus adherence and penetration proteins
09/04/2003CA2476654A1 Follistatin domain containing proteins
09/04/2003CA2476518A1 Compositions and methods for the treatment of immune related diseases
09/04/2003CA2475547A1 Method for the recombination of genetic elements
09/04/2003CA2475509A1 Treatment methods using anti-cd22 antibodies
09/04/2003CA2474751A1 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003CA2430580A1 Specialized dual condensation/epimerization domain in non-ribosomal peptide synthetase systems
09/03/2003EP1340981A2 Antibodies for detecting amphetamine derivatives
09/03/2003EP1340980A1 Derivatives of amphetamine, antibodies against said derivatives, reagent kits, methods of producing said antibodies, and methods of detecting said derivatives
09/03/2003EP1340979A2 Neuropeptide receptor and uses thereof
09/03/2003EP1340821A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340820A2 Method of detecting a variant of gh1 as indicator of growth hormone dysfunction
09/03/2003EP1340815A2 Determination of alpha-N-acetylgalactosaminidase activity
09/03/2003EP1340812A2 Functional domains in flavobacterium okeanokoites (Foki) restriction endonuclease
09/03/2003EP1340811A2 Antibodies with specificity for multiple adhesion molecules
09/03/2003EP1340769A1 CD4-gamma2 and CD4-IgG2 chimeras
09/03/2003EP1340079A2 S. aureus protein staau-r2, gene encoding it and uses thereof
09/03/2003EP1339867A2 ALTERATIONS IN THE LONG QT SYNDROME GENES i KVLQT1 /i AND i SCN5A /i AND METHODS FOR DETECTING SAME
09/03/2003EP1339856A1 Production of heterologous polypeptides in yeast
09/03/2003EP1339854A2 Lipid metabolism enzymes
09/03/2003EP1339848A2 A novel protein selectively expressed in osteoblasts
09/03/2003EP1339847A2 Transforming growth factor-beta-related molecules and uses thereof
09/03/2003EP1339846A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339845A2 Adipocyte complemented related protein zacrp3x2
09/03/2003EP1339843A2 Human transporter proteins nucleic acid molecules encoding them and uses thereof
09/03/2003EP1339842A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
09/03/2003EP1339840A2 Schizophrenia-related voltage-gated ion channel gene and protein
09/03/2003EP1339837A2 Prolyl endoprotease from aspergillus niger
09/03/2003EP1339834A2 Enzymes
09/03/2003EP1339750A2 Process for selecting anti-angiogenesis antibody fragments, anti-angiogenesis antibody fragments thus obtained and their use
09/03/2003EP1339748A2 G-protein coupled receptors
09/03/2003EP1339744A2 Production of recombinant bmp-2
09/03/2003EP1339735A1 Method for preparing tryptophan rich peptides
09/03/2003EP1339715A2 Heterocyclic ether substituted imidazoquinolines
09/03/2003EP1339427A2 Method of producing biospecific molecules by protein trans-splicing
09/03/2003EP0914614B1 CHARPERONES CAPABLE OF BINDING TO PRION PROTEINS AND DISTINGUISHING THE ISOFORMS PrPc AND PrPsc
09/03/2003EP0857210B1 Therapeutic antiangiogenic compositions and methods
09/03/2003EP0833670B1 Vaccine against rotavirus infection comprising peptides of viral enterotoxin nsp4
09/03/2003EP0828844B1 Promoters for gene expression
09/03/2003EP0765172B1 Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
09/03/2003EP0737209B1 Metal ion-ligand coordination complexes, antibodies directed thereto, and assays using such antibodies
09/03/2003EP0711349B1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
09/03/2003EP0660874B1 Recombinant dnase b derived from streptococcus pyogenes
09/03/2003EP0607297B1 Hormone analogs with multiple ctp extensions
09/03/2003CN1440459A Expression system
09/03/2003CN1440456A Sentinel virus Ôàí"
09/03/2003CN1440424A Antibody selective for tumor necrosis factor-related apoptosis-inducing ligand receptor and use thereof
09/03/2003CN1439720A Soya protein oligopeptides production